COVID-19 Exposure Unmasking Systemic Amyloidosis With Hepatic Predominance

Jose R Russe-Russe1, Chiya Abramowitz2, James R Pellegrini1

  • 1Internal Medicine, Nassau University Medical Center, East Meadow, USA.

Cureus
|December 7, 2022
PubMed
Summary

COVID-19 infection may accelerate systemic amyloidosis, particularly hepatic involvement, by triggering an effective immune response. This study explores amyloid light chain (AL) and serum amyloid A (AA) protein roles in COVID-19, examining their impact on disease severity.